Abstract：Objective To study the expression and significance of ubiquitin-specific protease 7 (USP7) and the key factors of the Wnt signaling pathway in the lung tissue of preterm rats after hyperoxia exposure. Methods A total of 180 preterm neonatal Wistar rats were randomly divided into an air control group, an air intervention group, a hyperoxia control group, and a hyperoxia intervention group, with 45 rats in each group. Lung injury was induced by hyperoxia exposure in the hyperoxia groups. The preterm rats in the intervention groups were given intraperitoneal injection of the USP7 specific inhibitor P5091 (5 mg/kg) every day. The animals were sacrificed on days 3, 5, and 9 of the experiment to collect lung tissue specimens. Hematoxylin-eosin staining was used to observe the pathological changes of lung tissue. RT-PCR and Western blot were used to measure the mRNA and protein expression levels of USP7 and the key factors of the Wnt signaling pathway β-catenin and α-smooth muscle actin (α-SMA) in lung tissue. Results The air groups had normal morphology and structure of lung tissue; on days 3 and 5, the hyperoxia control group showed obvious alveolar compression and disordered structure, with obvious inflammatory cells, erythrocyte diapedesis, and interstitial edema. On day 9, the hyperoxia control group showed alveolar structural disorder and obvious thickening of the alveolar septa. Compared with the hyperoxia control group at the corresponding time points, the hyperoxia intervention group had significantly alleviated disordered structure, inflammatory cell infiltration, and bleeding in lung tissue. At each time point, the hyperoxia groups had a significantly lower radial alveolar count (RAC) than the corresponding air groups (P < 0.05), and the hyperoxia intervention group had a significantly higher RAC than the hyperoxia control group (P < 0.05). On days 3, 5, and 9 of the experiment, the hyperoxia groups had significantly higher mRNA expression of USP7 and β-catenin and protein expression of USP7, β-catenin, and α-SMA than the corresponding air groups (P < 0.05). Compared with the hyperoxia control group, the hyperoxia intervention group had significant reductions in the mRNA expression of β-catenin and the protein expression of β-catenin and α-SMA (P < 0.05), while there were no significant differences in the mRNA and protein expression of USP7 between the hyperoxia intervention and hyperoxia control groups (P > 0.05). There were no significant differences in the mRNA expression of USP7 and β-catenin and the protein expression of USP7, β-catenin, and α-SMA between the air intervention and air control groups (P > 0.05). Conclusions Hyperoxia exposure can activate the Wnt/β-catenin signaling pathway, and USP7 may participate in hyperoxic lung injury through the Wnt/β-catenin signaling pathway. The USP7 specific inhibitor P5091 may accelerate the degradation of β-catenin by enhancing its ubiquitination, reduce lung epithelial-mesenchymal transition, and thus exert a certain protective effect against hyperoxic lung injury.
HUANG Xiao-Yue,QUAN Yu-Feng,YAN Long-Li et al. Expression of ubiquitin-specific protease 7 in lung tissue of preterm rats after hyperoxia exposure[J]. CJCP, 2020, 22(12): 1331-1337.
Hosseinzadeh A, Javad-Moosavi SA, Reiter RJ, et al. Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin[J]. Life Sci, 2018, 201:17-29.
Novellasdemunt L, Foglizzo V, Cuadrado L, et al. USP7 is a tumor-specific WNT activator for APC-mutated colorectal cancer by mediating β-catenin deubiquitination[J]. Cell Rep, 2017, 21(3):612-627.
Geurink PP, van der Heden van Noort GJ, Mulder MPC, et al. Profiling DUBs and Ubl-specific proteases with activity-based probes[J]. Methods Enzymol, 2019, 618:357-387.
[14]
Xu J, Taya S, Kaibuchi K, et al. Spatially and temporally specific expression in mouse hippocampus of Usp9x, a ubiquitin-specific protease involved in synaptic development[J]. J Neurosci Res, 2005, 80(1):47-55.
[15]
Yun SI, Kim HH, Yoon JH, et al. Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer[J]. Mol Oncol, 2015, 9(9):1834-1851.
[16]
An T, Gong Y, Li X, et al. USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth[J]. Biochem Pharmacol, 2017, 131:29-39.
[17]
Li J, Han Y, Zhang H, et al. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA[J]. Biochem Biophys Res Commun, 2019, 512(3):479-485.
[18]
Wang J, Li HY, Su ZB. Stabilization of the histone acetyltransferase Tip60 by deubiquitinating enzyme USP7 stimulates the release of pro-inflammatory mediators in acute lung injury[J]. J Mol Med (Berl), 2020, 98(6):907-921.
[19]
Carrà G, Panuzzo C, Torti D, et al. Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia:a strategy to overcome TP53 mutated/deleted clones[J]. Oncotarget, 2017, 8(22):35508-35522.
[20]
Li X, Kong L, Yang Q, et al. Parthenolide inhibits ubiquitin-specific peptidase 7(USP7), Wnt signaling, and colorectal cancer cell growth[J]. J Biol Chem, 2020, 295(11):3576-3589.
[21]
Mitxitorena I, Somma D, Mitchell JP, et al. The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-κB subunits[J]. J Biol Chem, 2020, 295(33):11754-11763.
[22]
朱晓丹. 锌指蛋白A20对急性肺损伤炎症反应的调控及机制研究[D]. 上海:复旦大学, 2012.
[23]
Tan ZX, Chen YH, Xu S, et al. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice[J]. Toxicol Lett, 2016, 240(1):161-171.
[24]
Darby IA, Zakuan N, Billet F, et al. The myofibroblast, a key cell in normal and pathological tissue repair[J]. Cell Mol Life Sci, 2016, 73(6):1145-1157.
